Press Releases

FEBRUARY 9, 2021

Taiga Treats First Cancer Patient in TBX-3400-003 Clinical Trial in Israel

AURORA, Colo. & PETACH TIQWA, Israel -- Taiga Biotechnologies, Inc., a cell-based immunotherapy company, announced today that a colorectal cancer patient at the Davidoff Cancer Center, Beilenson Hospital, Rabin Medical Center, Petach Tikva, was the first recipient of a treatment designed to treat drug-resistant solid tumors in the company's recently approved Israeli trial. [...]


JUNE 13, 2016

Taiga Biotechnologies Awarded Orphan Drug Designation for Stem Cell Therapy

AURORA, Colo. -- The Food and Drug Administration has given Taiga Biotechnologies, Inc. Orphan Drug Designation for an experimental product designed to treat children with a rare immune deficiency that forces them to live in a sterile environment. [...]